Xylem (XYL) Stock Forecast & Price Target

Xylem reported strong financial performance, with sales reaching $656.0 million in 3Q25, reflecting a 5.3% year-over-year increase, and demonstrating a recovery in organic revenue growth, which is solidly in the mid-single digits. The company's ability to achieve organic growth was bolstered by strong demand, effective backlog execution, and successful price adjustments, despite challenges posed by tariffs and some demand impacts. Furthermore, the strategic integration of Evoqua is anticipated to significantly enhance Xylem's growth profile and operational performance over the next few years, particularly boosting margins.

Xylem's recent financial performance has prompted concerns, as the company's 2026 EPS guidance midpoint was reported slightly below consensus expectations, leading to an 8% stock sell-off following the fourth quarter results. The ongoing economic challenges in China, characterized by local competitive pressures and reduced demand in the utility, commercial, and industrial sectors, are expected to negatively impact revenue and margins, particularly in the Water Infrastructure and Applied Water segments. Furthermore, the anticipated effects of the 80/20 simplification strategy may suppress overall segment growth, contributing to a projected low single-digit revenue decline in the first quarter of 2026 before potential sequential improvement later in the year.